These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32900251)

  • 41. Synthesis of new ultrasonic-assisted palladium oxide nanoparticles: an in vitro evaluation on cytotoxicity and DNA/BSA binding properties.
    Sorinezami Z; Mansouri-Torshizi H; Aminzadeh M; Ghahghaei A; Jamgohari N; Heidari Majd M
    J Biomol Struct Dyn; 2019 Oct; 37(16):4238-4250. PubMed ID: 30600777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of vitamin-cisplatin-loaded chitosan nano-particles for chemoprevention and cancer fatigue.
    Othayoth R; Mathi P; Bheemanapally K; Kakarla L; Botlagunta M
    J Microencapsul; 2015; 32(6):578-88. PubMed ID: 26218628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy.
    Ji S; Xu J; Zhang B; Yao W; Xu W; Wu W; Xu Y; Wang H; Ni Q; Hou H; Yu X
    Cancer Biol Ther; 2012 Feb; 13(4):206-15. PubMed ID: 22354009
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies.
    Zheng Y; Cai Z; Song X; Chen Q; Bi Y; Li Y; Hou S
    J Drug Target; 2009 May; 17(4):294-303. PubMed ID: 19255895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biodegradable polymeric system for cisplatin delivery: development, in vitro characterization and investigation of toxicity profile.
    Alam N; Khare V; Dubey R; Saneja A; Kushwaha M; Singh G; Sharma N; Chandan B; Gupta PN
    Mater Sci Eng C Mater Biol Appl; 2014 May; 38():85-93. PubMed ID: 24656356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microemulsion and bovine serum albumin nanoparticles as a novel hybrid nanocarrier system for efficient multifunctional drug delivery.
    Gharbavi M; Danafar H; Sharafi A
    J Biomed Mater Res A; 2020 Aug; 108(8):1688-1702. PubMed ID: 32196926
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biophysical study of cisplatin loaded albumin-gold nanoparticle and its interaction with glycans of gp60 receptor.
    Jaiswal VD; Pangam DS; Dongre PM
    Int J Biol Macromol; 2023 Mar; 231():123368. PubMed ID: 36682660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles.
    Zhao D; Zhao X; Zu Y; Li J; Zhang Y; Jiang R; Zhang Z
    Int J Nanomedicine; 2010 Sep; 5():669-77. PubMed ID: 20957218
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional Albumin Nanoformulations to Fight Adrenocortical Carcinoma: a Redox-Responsive Approach.
    Curcio M; Avena P; Cirillo G; Casaburi I; Spizzirri UG; Nicoletta FP; Iemma F; Pezzi V
    Pharm Res; 2020 Feb; 37(3):55. PubMed ID: 32060727
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting.
    Li FQ; Su H; Wang J; Liu JY; Zhu QG; Fei YB; Pan YH; Hu JH
    Int J Pharm; 2008 Feb; 349(1-2):274-82. PubMed ID: 17870261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery.
    Bilensoy E; Gürkaynak O; Doğan AL; Hincal AA
    Int J Pharm; 2008 Jan; 347(1-2):163-70. PubMed ID: 17689901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeted nanoparticles assembled via complexation of boronic-acid-containing targeting moieties to diol-containing polymers.
    Han H; Davis ME
    Bioconjug Chem; 2013 Apr; 24(4):669-77. PubMed ID: 23461746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ATP-loaded biomimetic nanoparticles as controlled release system for extracellular drugs in cancer applications.
    Díaz-Saldívar P; Huidobro-Toro JP
    Int J Nanomedicine; 2019; 14():2433-2447. PubMed ID: 31040666
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Folate-targeted nanoparticles based on albumin and albumin/alginate mixtures as controlled release systems of tamoxifen: synthesis and in vitro characterization.
    Martínez A; Olmo R; Iglesias I; Teijón JM; Blanco MD
    Pharm Res; 2014 Jan; 31(1):182-93. PubMed ID: 23921489
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preparation and characterization of PLGA-β-CD polymeric nanoparticles containing methotrexate and evaluation of their effects on T47D cell line.
    Gorjikhah F; Azizi Jalalian F; Salehi R; Panahi Y; Hasanzadeh A; Alizadeh E; Akbarzadeh A; Davaran S
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):432-440. PubMed ID: 27002986
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preparation, characterization and pharmacokinetic studies of tacrolimus-dimethyl-β-cyclodextrin inclusion complex-loaded albumin nanoparticles.
    Gao S; Sun J; Fu D; Zhao H; Lan M; Gao F
    Int J Pharm; 2012 May; 427(2):410-6. PubMed ID: 22326299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of a novel liposomal nanoparticle formulation of cisplatin to breast cancer therapy.
    Ghafari M; Haghiralsadat F; Khanamani Falahati-Pour S; Zavar Reza J
    J Cell Biochem; 2020 Jul; 121(7):3584-3592. PubMed ID: 31907989
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In situ preparation of water-soluble ginsenoside Rh2-entrapped bovine serum albumin nanoparticles: in vitro cytocompatibility studies.
    Singh P; Kim YJ; Singh H; Ahn S; Castro-Aceituno V; Yang DC
    Int J Nanomedicine; 2017; 12():4073-4084. PubMed ID: 28603419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reversible polyelectrolyte capsules as carriers for protein delivery.
    Anandhakumar S; Nagaraja V; Raichur AM
    Colloids Surf B Biointerfaces; 2010 Jul; 78(2):266-74. PubMed ID: 20400274
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hybrid of niosomes and bio-synthesized selenium nanoparticles as a novel approach in drug delivery for cancer treatment.
    Gharbavi M; Johari B; Mousazadeh N; Rahimi B; Leilan MP; Eslami SS; Sharafi A
    Mol Biol Rep; 2020 Sep; 47(9):6517-6529. PubMed ID: 32767222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.